OSTX
OS Therapies Incorporated
AMEX: OSTX · HEALTHCARE · BIOTECHNOLOGY
$1.25
+1.63% today
Updated 2026-10-28
Market cap
$58.51M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$1 – $2
Volume
0.7M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C2.8
Quality
F3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-29.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$8.50
+580.00%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -29.63 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-5.53M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-6.25M | $-7.79M | $-8.88M | $-28.75M | $-8.63M |
| EPS | — | — | — | — | $-1.08 |
| Free cash flow | $-3.79M | $-3.01M | $-7.28M | $-14.24B | $-5.53M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
OS Therapies Incorporated trades at $1.25. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -29.63, it sits in the distress.
Frequently asked questions
What is OS Therapies Incorporated's stock price?
OS Therapies Incorporated (OSTX) trades at $1.25.
Is OS Therapies Incorporated overvalued?
OS Therapies Incorporated carries a Smart Value Score of 16/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of OS Therapies Incorporated (OSTX)?
The 12-month analyst consensus target is $8.50, about 580.0% above the current $1.25. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
OS Therapies Incorporated's Altman Z-Score is -29.63, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio—
ROE-914.00%
Beta-0.64
50D MA$1.60
200D MA$1.57
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—